Please Wait.....
Report
Empty Capsules Market by Type (Gelatin (Porcine, Bovine, Bonemeal), Non-gelatin (HPMC, Starch)), Functionality (Immediate-release, Sustained-Release, Delayed-release),Therapeutic Application (Antibiotic, Dietary, Antacid, CVD) - Global Forecast to 2029
Market Report I 2024-06-21 I 320 Pages I MarketsandMarkets
The empty capsules market is projected to reach USD 4.2 billion by 2029 from an estimated USD 3.1 billion in 2024, at a CAGR of 6.3% during the forecast period. This market's growth can be attributed to the growth in the pharmaceutical market, the increasing number of clinical trials and R&D activities, and the expansion of over-the-counter medications.
"The gelatin capsules segment accounted for the largest share by type in 2023."
In 2023, the gelatin segment accounted for the largest share of type in the global empty capsules market. Factors such as availability of gelatin empty capsules in various colors, sizes, and printing options enables pharmaceutical companies to tailor their products to specific market segments, enhancing brand recognition and consumer appeal are expected to drive the segmeng growth.
""The Asia Pacific region is growing in the empty capsules market during the forecast period of 2024-2029."
The Asia Pacific region is expected to grow at the highest growth rate during the forecast period. The expanding pharmaceutical industry, combined with increasing healthcare spending, creates a strong demand for these capsules as crucial components in drug delivery systems. Additionally, the rising prevalence of chronic diseases and infectious illnesses necessitates diverse pharmaceutical formulations, further fueling the need for empty capsules. The growing awareness of preventive healthcare and the popularity of dietary supplements also contribute to market growth. Moreover, the region's robust manufacturing capabilities and cost-effective production methods enhance the accessibility of empty capsules across various pharmaceutical and nutraceutical applications. Additionally, favorable government policies and initiatives supporting healthcare infrastructure development and pharmaceutical innovation reinforce the market's expansion.
The primary interviews conducted for this report can be categorized as follows:
- By Respondent: Supply Side- 80% and Demand Side 20%
- By Designation: Managers - 35%, CXO & Directors - 20%, and Executives - 45%
- By Region: North America -20%, Europe -25%, Asia-Pacific -40%, Latin America -10% and Middle East & Africa- 5%
List of Companies Profiled in the Report:
- Capsugel (Lonza) (Switzerland)
- ACG (India)
- QUALICAPS (Roquette Freres) (France)
- SUHEUNG (South Korea)
- Shanxi Guangsheng Capsule Limited (China)
- CapsCanada (Lyfe Group) (US)
- HealthCaps India (India)
- Nectar Lifesciences Ltd. (India)
- Sunil Healthcare Limited (India)
- Farmacapsulas (Colombia)
- NATURAL CAPSULES LIMITED (India)
- Erawat Pharma Limited (India)
- Qingdao Yiqing Biotechnology Co., Ltd. (Baotou Dongbao Bio-Tech Co., Ltd.) (China)
- Fortcaps ( Kumar Organic Products Limited) (India)
- Comed Chemicals Limited (India)
- Roxlor (US)
- Medisca Inc. (US)
- Zhejiang Yuexi Capsule Co. (China)
- ZHEJIANG HUILI CAPSULES CO., LTD (China)
- Shaoxing Zhongya Capsule Co., Ltd. (China)
- Shing Lih Fang Enterprise Co., Ltd. (Taiwan)
- Chemcaps Limited (India)
- SNAIL PHARMA INDUSTRY (China)
- SavoiurCaps (India)
- Shanxi JC Biological Technology CO. (China)
- Shaoxing Kangke Capsule Co., Ltd. (China)
- Lefancaps (Canada)
- BIO-CAPS INDIA LTD. (India)
- BioCaps Enterprise (US)
- Bright Pharma Caps (US)
- SHREE PHARMA CAPS (India)
Research Coverage:
This research report categorizes the empty capsules market by ((non-gelatin capsules (hydroxypropyl methylcellulose (HPMC) capsules, and pullulan & starch capsules), and gelatin capsules (porcine gelatin, bovine-derived gelatin, bone meal, and other gelatin sources), and), therapeutic application (antibiotic & antibacterial drugs, dietary supplements, antacid & antiflatulent preparations, antianemic preparations, anti-inflammatory drugs, cardiovascular therapy drugs, cough & cold drugs, other therapeutic applications), functionality (immediate-release capsules, sustained-release capsules, and delayed-release capsules), end user (pharmaceutical industry, nutraceutical industry, cosmetic industry, and research laboratories).
The report provides in-depth information on significant factors influencing the growth of the empty capsules market, including drivers, trends, challenges, and opportunities. A thorough analysis of major industry players has been undertaken to provide insights into their business profiles, products, key strategies, collaborations, partnerships, and agreements. Additionally, the report encompasses recent developments such as new product launches, mergers, and acquisitions within the empty capsules market.
Key Benefits of Buying the Report:
The report will help market leaders and new entrants by providing them with the closest approximations of the revenue numbers for the overall empty capsules market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their businesses and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, opportunities, and challenges.
The report provides insights on the following pointers:
- Analysis of key drivers (increasing demand for nutraceuticals and expansion of the Over-the-counter medications), restraints (cultural practices and dietary restrictions, and issues related to the safety and side effects of gelatin capsules), opportunities (expansion of capsule production in emerging countries and development of halal gelatin and vegetarian capsules), and challenges (rising prices and lower availability of raw materials in the gelatin industry and climate issues in the production and storage of empty capsules) influencing the growth of the market.
- Product Development/Innovation: Detailed insights on newly launched products of the empty capsules market
- Market Development: Comprehensive information about lucrative markets - the report analyses the market across varied regions.
- Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the empty capsules market
- Competitive Assessment: Capsugel (Lonza) (Switzerland), ACG (India), QUALICAPS (Roquette Freres) (France), SUHEUNG (South Korea), Shanxi Guangsheng Capsule Limited (China), CapsCanada (Lyfe Group) (US), HealthCaps India (India), Nectar Lifesciences Ltd. (India), Sunil Healthcare Limited (India), Farmacapsulas (Colombia), NATURAL CAPSULES LIMITED (India), Erawat Pharma Limited (India), Qingdao Yiqing Biotechnology Co., Ltd. (Baotou Dongbao Bio-Tech Co., Ltd.) (China), Fortcaps ( Kumar Organic Products Limited) (India), Comed Chemicals Limited (India), Roxlor (US), Medisca Inc. (US), Zhejiang Yuexi Capsule Co. (China), ZHEJIANG HUILI CAPSULES CO., LTD (China), Shaoxing Zhongya Capsule Co., Ltd. (China), Shing Lih Fang Enterprise Co., Ltd. (Taiwan), Chemcaps Limited (India), among others in the market.
1 INTRODUCTION 43
1.1 STUDY OBJECTIVES 43
1.2 MARKET DEFINITION 43
1.2.1 INCLUSIONS & EXCLUSIONS 44
1.3 MARKET SCOPE 44
1.3.1 MARKETS COVERED 44
1.3.2 REGIONS COVERED 45
1.3.3 YEARS CONSIDERED 45
1.4 UNITS CONSIDERED 46
1.4.1 CURRENCY/VALUE UNIT 46
1.4.2 VOLUME UNIT 46
1.5 STAKEHOLDERS 46
1.6 SUMMARY OF CHANGES 46
1.7 RECESSION IMPACT 47
2 RESEARCH METHODOLOGY 48
2.1 RESEARCH APPROACH 48
FIGURE 1 RESEARCH DESIGN 48
2.1.1 SECONDARY DATA 49
2.1.2 PRIMARY DATA 49
FIGURE 2 EMPTY CAPSULES MARKET: BREAKDOWN OF PRIMARIES 50
2.2 MARKET ESTIMATION METHODOLOGY 51
FIGURE 3 EMPTY CAPSULES MARKET SIZE ESTIMATION, BY VALUE (2023) 51
2.2.1 BOTTOM-UP APPROACH 51
FIGURE 4 MARKET SIZE ESTIMATION: APPROACH 1 (COMPANY REVENUE ANALYSIS-BASED ESTIMATION), 2023 52
FIGURE 5 EMPTY CAPSULES MARKET SIZE ESTIMATION, BY VOLUME (2023) 52
2.2.2 INSIGHTS FROM PRIMARY EXPERTS 54
FIGURE 6 INSIGHTS FROM PRIMARY EXPERTS 54
2.2.3 TOP-DOWN APPROACH 54
FIGURE 7 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH 54
2.3 MARKET GROWTH RATE PROJECTIONS 55
TABLE 1 IMPACT ANALYSIS OF SUPPLY-SIDE AND DEMAND-SIDE FACTORS 56
2.4 MARKET BREAKDOWN AND DATA TRIANGULATION 57
FIGURE 8 DATA TRIANGULATION METHODOLOGY 57
2.5 RESEARCH ASSUMPTIONS 58
2.6 RESEARCH LIMITATIONS 58
2.7 RISK ANALYSIS 59
TABLE 2 RISK ASSESSMENT ANALYSIS 59
2.8 RECESSION IMPACT ANALYSIS 59
3 EXECUTIVE SUMMARY 61
FIGURE 9 EMPTY CAPSULES MARKET, BY TYPE, 2024 VS. 2029 (USD MILLION) 61
FIGURE 10 EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2024 VS. 2029 (USD MILLION) 62
FIGURE 11 EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2024 VS. 2029 (USD MILLION) 62
FIGURE 12 EMPTY CAPSULES MARKET, BY END USER, 2024 VS. 2029 (USD MILLION) 63
FIGURE 13 GEOGRAPHIC SNAPSHOT OF EMPTY CAPSULES MARKET 64
4 PREMIUM INSIGHTS 65
4.1 EMPTY CAPSULES MARKET OVERVIEW 65
FIGURE 14 INCREASING DEMAND FOR NUTRACEUTICALS TO DRIVE MARKET 65
4.2 NORTH AMERICA: EMPTY CAPSULES MARKET, BY TYPE AND COUNTRY (2023) 66
FIGURE 15 GELATIN CAPSULES SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN 2023 66
4.3 EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION (2023) 66
FIGURE 16 ANTIBIOTIC & ANTIBACTERIAL DRUGS SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN 2023 66
4.4 EMPTY CAPSULES MARKET, BY END USER (2023) 67
FIGURE 17 PHARMACEUTICAL INDUSTRY SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN 2023 67
4.5 EMPTY CAPSULES MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 67
FIGURE 18 ASIA PACIFIC COUNTRIES TO REGISTER HIGHER GROWTH RATE DURING FORECAST PERIOD 67
5 MARKET OVERVIEW 68
5.1 INTRODUCTION 68
5.2 MARKET DYNAMICS 68
FIGURE 19 EMPTY CAPSULES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 68
TABLE 3 EMPTY CAPSULES MARKET: IMPACT ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 69
5.2.1 DRIVERS 69
5.2.1.1 Increasing demand for nutraceuticals 69
5.2.1.2 Growing focus on pharmaceutical development and subsequent increase in clinical trials 70
FIGURE 20 TOTAL PRESCRIPTION DRUG SALES, 2014?2028 (USD BILLION) 70
FIGURE 21 NUMBER OF CLINICAL TRIALS REGISTERED, 2001?2023 71
5.2.1.3 Advancements in capsule delivery technologies 71
5.2.1.4 Benefits of capsules over other dosage forms 72
5.2.1.5 Growing preference for self-medication and OTC drugs 72
5.2.2 RESTRAINTS 73
5.2.2.1 Dietary restrictions associated with gelatin consumption 73
5.2.2.2 Issues related to safety and efficacy 73
5.2.3 OPPORTUNITIES 74
5.2.3.1 Expansion of capsule production in emerging economies 74
5.2.3.2 Development of halal gelatin and vegetarian capsules 74
5.2.4 CHALLENGES 75
5.2.4.1 Variable prices and low availability of raw materials 75
5.2.4.2 Challenges associated with storage of empty capsules 75
5.3 INDUSTRY TRENDS 76
5.3.1 RISING DEMAND FOR EMPTY CAPSULES IN NUTRACEUTICALS & COSMETICS 76
5.3.2 GROWING PREFERENCE FOR VEGETARIAN/NON-GELATIN CAPSULES 76
5.4 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES 77
FIGURE 22 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES IN EMPTY CAPSULES MARKET 78
5.5 SUPPLY CHAIN ANALYSIS 78
FIGURE 23 EMPTY CAPSULES MARKET: SUPPLY CHAIN ANALYSIS 79
5.6 PRICING ANALYSIS 79
TABLE 4 AVERAGE SELLING PRICE TREND OF EMPTY CAPSULES, BY TYPE (2021?2023) 80
TABLE 5 AVERAGE PRICE OF EMPTY CAPSULES, BY REGION (2023) 80
5.7 TECHNOLOGY ANALYSIS 80
5.7.1 KEY TECHNOLOGIES 80
5.7.1.1 Advanced quality control systems 80
5.7.1.2 Automated encapsulation machines 81
5.7.2 COMPLEMENTARY TECHNOLOGIES 81
5.7.2.1 3D printing 81
5.7.2.2 Enteric capsule technologies 81
5.7.3 ADJACENT TECHNOLOGIES 82
5.7.3.1 Nanotechnology 82
5.7.3.2 AI in capsule manufacturing 82
5.8 VALUE CHAIN ANALYSIS 82
FIGURE 24 EMPTY CAPSULES MARKET: VALUE CHAIN ANALYSIS 83
5.9 ECOSYSTEM ANALYSIS 84
FIGURE 25 EMPTY CAPSULES MARKET: ECOSYSTEM ANALYSIS 84
5.9.1 EMPTY CAPSULES MARKET: ROLE OF RAW MATERIAL VENDORS 85
TABLE 6 EMPTY CAPSULES MARKET: ROLE OF RAW MATERIAL VENDORS 85
5.9.2 EMPTY CAPSULES MARKET: ROLE OF PRODUCT PROVIDERS 85
TABLE 7 EMPTY CAPSULES MARKET: ROLE OF PRODUCT PROVIDERS 85
5.9.3 EMPTY CAPSULES MARKET: ROLE OF END USERS 86
TABLE 8 EMPTY CAPSULES MARKET: ROLE OF END USERS 86
5.9.4 EMPTY CAPSULES MARKET: ROLE OF REGULATORY AUTHORITIES 86
TABLE 9 EMPTY CAPSULES MARKET: ROLE OF REGULATORY AUTHORITIES 87
5.10 PORTER'S FIVE FORCES ANALYSIS 87
FIGURE 26 EMPTY CAPSULES MARKET: PORTER'S FIVE FORCES ANALYSIS 87
TABLE 10 EMPTY CAPSULES MARKET: PORTER'S FIVE FORCES ANALYSIS 88
5.10.1 THREAT OF NEW ENTRANTS 88
5.10.2 THREAT OF SUBSTITUTES 88
5.10.3 BARGAINING POWER OF SUPPLIERS 88
5.10.4 BARGAINING POWER OF BUYERS 88
5.10.5 INTENSITY OF COMPETITIVE RIVALRY 89
5.11 PATENT ANALYSIS 89
5.11.1 PATENT METHODOLOGY 89
5.11.2 PATENTS FILED, BY DOCUMENT TYPE, 2014?2024 89
TABLE 11 PATENTS FILED, 2014?2024 89
5.11.3 INNOVATION & PATENT APPLICATIONS 89
FIGURE 27 TOTAL NUMBER OF PATENTS GRANTED, 2014?2024 90
5.11.4 TOP APPLICANTS 90
FIGURE 28 TOP TEN PLAYERS WITH HIGHEST NUMBER OF PATENT APPLICATIONS, 2014?2024 90
TABLE 12 TOP 20 PATENT OWNERS IN EMPTY CAPSULES, 2014?2024 91
TABLE 13 INDICATIVE LIST OF PATENTS IN EMPTY CAPSULES MARKET, 2023?2024 92
5.12 KEY CONFERENCES & EVENTS, 2024-2025 94
TABLE 14 EMPTY CAPSULES MARKET: DETAILED LIST OF CONFERENCES & EVENTS, 2024?2025 94
5.13 TRADE ANALYSIS 95
TABLE 15 IMPORT VALUE FOR HS CODE 960200 (TOP 30 COUNTRIES), 2019?2023 (USD THOUSAND) 95
TABLE 16 EXPORT VALUE FOR HS CODE 960200 (TOP 30 COUNTRIES), 2019?2023 (USD THOUSAND) 96
TABLE 17 IMPORT VOLUME FOR HS CODE 960200 (TOP 30 COUNTRIES), 2019?2023 (TONS) 97
TABLE 18 EXPORT VOLUME FOR HS CODE 960200 (TOP 30 COUNTRIES), 2019?2023 (TONS) 98
5.14 REGULATORY LANDSCAPE 99
5.14.1 REGULATORY SCENARIO 99
5.14.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 101
TABLE 19 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 101
TABLE 20 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 102
TABLE 21 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 103
TABLE 22 REST OF THE WORLD: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 104
5.15 KEY STAKEHOLDERS AND BUYING CRITERIA 105
5.15.1 KEY STAKEHOLDERS IN BUYING PROCESS 105
FIGURE 29 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR EMPTY CAPSULES 105
5.15.2 BUYING CRITERIA FOR EMPTY CAPSULES 106
FIGURE 30 KEY BUYING CRITERIA FOR EMPTY CAPSULES 106
TABLE 23 BUYING CRITERIA FOR EMPTY CAPSULE PRODUCTS, BY END USER 106
5.16 INVESTMENT & FUNDING SCENARIO 107
5.17 INSIGHTS ON PHARMACEUTICAL GELATIN MARKET 108
6 EMPTY CAPSULES MARKET, BY TYPE 110
6.1 INTRODUCTION 111
TABLE 24 EMPTY CAPSULES MARKET, BY TYPE, 2022-2029 (USD MILLION) 111
TABLE 25 EMPTY CAPSULES MARKET, BY TYPE, 2022-2029 (BILLION UNITS) 111
6.2 GELATIN CAPSULES 112
TABLE 26 GELATIN CAPSULES MARKET, BY TYPE, 2022-2029 (USD MILLION) 112
TABLE 27 GELATIN CAPSULES MARKET, BY REGION, 2022-2029 (USD MILLION) 113
TABLE 28 GELATIN CAPSULES MARKET, BY REGION, 2022-2029 (BILLION UNITS) 113
TABLE 29 NORTH AMERICA: GELATIN CAPSULES MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 113
TABLE 30 EUROPE: GELATIN CAPSULES MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 114
TABLE 31 ASIA PACIFIC: GELATIN CAPSULES MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 114
TABLE 32 LATIN AMERICA: GELATIN CAPSULES MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 114
6.2.1 PORCINE GELATIN 115
6.2.1.1 Porcine gelatin segment to dominate market 115
TABLE 33 PORCINE GELATIN CAPSULES MARKET, BY REGION, 2022-2029 (USD MILLION) 115
TABLE 34 NORTH AMERICA: PORCINE GELATIN CAPSULES MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 116
TABLE 35 EUROPE: PORCINE GELATIN CAPSULES MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 116
TABLE 36 ASIA PACIFIC: PORCINE GELATIN CAPSULES MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 116
TABLE 37 LATIN AMERICA: PORCINE GELATIN CAPSULES MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 117
6.2.2 BOVINE-DERIVED GELATIN 117
6.2.2.1 Growing demand for stabilizing agents in pharmaceutical formulations to drive market 117
TABLE 38 BOVINE-DERIVED GELATIN CAPSULES MARKET, BY REGION, 2022-2029 (USD MILLION) 118
TABLE 39 NORTH AMERICA: BOVINE-DERIVED GELATIN CAPSULES MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 118
TABLE 40 EUROPE: BOVINE-DERIVED GELATIN CAPSULES MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 118
TABLE 41 ASIA PACIFIC: BOVINE-DERIVED GELATIN CAPSULES MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 119
TABLE 42 LATIN AMERICA: BOVINE-DERIVED GELATIN CAPSULES MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 119
6.2.3 BONEMEAL GELATIN 119
6.2.3.1 Ability to be used as substitutes for porcine gelatin to boost demand 119
TABLE 43 BONEMEAL GELATIN CAPSULES MARKET, BY REGION, 2022-2029 (USD MILLION) 120
TABLE 44 NORTH AMERICA: BONEMEAL GELATIN CAPSULES MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 120
TABLE 45 EUROPE: BONEMEAL GELATIN CAPSULES MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 121
TABLE 46 ASIA PACIFIC: BONEMEAL GELATIN CAPSULES MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 121
TABLE 47 LATIN AMERICA: BONEMEAL GELATIN CAPSULES MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 122
6.2.4 OTHER GELATIN SOURCES 122
TABLE 48 OTHER GELATIN SOURCES MARKET, BY REGION, 2022-2029 (USD MILLION) 122
TABLE 49 NORTH AMERICA: OTHER GELATIN SOURCES MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 123
TABLE 50 EUROPE: OTHER GELATIN SOURCES MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 123
TABLE 51 ASIA PACIFIC: OTHER GELATIN SOURCES MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 123
TABLE 52 LATIN AMERICA: OTHER GELATIN SOURCES MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 124
6.3 NON-GELATIN CAPSULES 124
TABLE 53 NON-GELATIN CAPSULES MARKET, BY TYPE, 2022-2029 (USD MILLION) 125
TABLE 54 NON-GELATIN CAPSULES MARKET, BY REGION, 2022-2029 (USD MILLION) 125
TABLE 55 NON-GELATIN CAPSULES MARKET, BY REGION, 2022-2029 (BILLION UNITS) 125
TABLE 56 NORTH AMERICA: NON-GELATIN CAPSULES MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 126
TABLE 57 EUROPE: NON-GELATIN CAPSULES MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 126
TABLE 58 ASIA PACIFIC: NON-GELATIN CAPSULES MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 126
TABLE 59 LATIN AMERICA: NON-GELATIN CAPSULES MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 127
6.3.1 HYDROXYPROPYL METHYLCELLULOSE (HPMC) CAPSULES 127
6.3.1.1 Growing applications in pharmaceutical, nutraceutical, and OTC formulations to drive market 127
TABLE 60 HYDROXYPROPYL METHYLCELLULOSE CAPSULES MARKET, BY REGION, 2022-2029 (USD MILLION) 128
TABLE 61 NORTH AMERICA: HYDROXYPROPYL METHYLCELLULOSE CAPSULES MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 128
TABLE 62 EUROPE: HYDROXYPROPYL METHYLCELLULOSE CAPSULES MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 129
TABLE 63 ASIA PACIFIC: HYDROXYPROPYL METHYLCELLULOSE CAPSULES MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 129
TABLE 64 LATIN AMERICA: HYDROXYPROPYL METHYLCELLULOSE CAPSULES MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 130
6.3.2 PULLULAN & STARCH CAPSULES 130
6.3.2.1 High manufacturing cost to restrain market 130
TABLE 65 PULLULAN & STARCH CAPSULES MARKET, BY REGION, 2022-2029 (USD MILLION) 131
TABLE 66 NORTH AMERICA: PULLULAN & STARCH CAPSULES MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 131
TABLE 67 EUROPE: PULLULAN & STARCH CAPSULES MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 131
TABLE 68 ASIA PACIFIC: PULLULAN & STARCH CAPSULES MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 132
TABLE 69 LATIN AMERICA: PULLULAN & STARCH CAPSULES MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 132
7 EMPTY CAPSULES MARKET, BY FUNCTIONALITY 133
7.1 INTRODUCTION 134
TABLE 70 EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2022-2029 (USD MILLION) 134
7.2 IMMEDIATE-RELEASE CAPSULES 134
7.2.1 RAPID ABSORPTION AND BROAD APPLICATIONS TO PROPEL MARKET 134
TABLE 71 IMMEDIATE-RELEASE CAPSULES MARKET, BY REGION, 2022-2029 (USD MILLION) 135
TABLE 72 NORTH AMERICA: IMMEDIATE-RELEASE CAPSULES MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 135
TABLE 73 EUROPE: IMMEDIATE-RELEASE CAPSULES MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 135
TABLE 74 ASIA PACIFIC: IMMEDIATE-RELEASE CAPSULES MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 136
TABLE 75 LATIN AMERICA: IMMEDIATE-RELEASE CAPSULES MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 136
7.3 SUSTAINED-RELEASE CAPSULES 136
7.3.1 CONTROLLED DRUG RELEASE FOR CHRONIC DISEASE MANAGEMENT TO DRIVE MARKET 136
TABLE 76 SUSTAINED-RELEASE CAPSULES MARKET, BY REGION, 2022-2029 (USD MILLION) 137
TABLE 77 NORTH AMERICA: SUSTAINED-RELEASE CAPSULES MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 137
TABLE 78 EUROPE: SUSTAINED-RELEASE CAPSULES MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 138
TABLE 79 ASIA PACIFIC: SUSTAINED-RELEASE CAPSULES MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 138
TABLE 80 LATIN AMERICA: SUSTAINED-RELEASE CAPSULES MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 139
7.4 DELAYED-RELEASE CAPSULES 139
7.4.1 GROWING PREFERENCE FOR TARGETED DRUG DELIVERY TO FUEL MARKET 139
TABLE 81 DELAYED-RELEASE CAPSULES MARKET, BY REGION, 2022-2029 (USD MILLION) 140
TABLE 82 NORTH AMERICA: DELAYED-RELEASE CAPSULES MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 140
TABLE 83 EUROPE: DELAYED-RELEASE CAPSULES MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 141
TABLE 84 ASIA PACIFIC: DELAYED-RELEASE CAPSULES MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 141
TABLE 85 LATIN AMERICA: DELAYED-RELEASE CAPSULES MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 142
8 EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION 143
8.1 INTRODUCTION 144
TABLE 86 EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2022-2029 (USD MILLION) 144
8.2 ANTIBIOTIC & ANTIBACTERIAL DRUGS 144
8.2.1 RISING INCIDENCE OF INFECTIOUS DISEASES TO DRIVE MARKET 144
TABLE 87 EMPTY CAPSULES MARKET FOR ANTIBIOTICS & ANTIBACTERIAL DRUGS, BY REGION, 2022-2029 (USD MILLION) 145
TABLE 88 NORTH AMERICA: EMPTY CAPSULES MARKET FOR ANTIBIOTICS & ANTIBACTERIAL DRUGS, BY COUNTRY, 2022-2029 (USD MILLION) 145
TABLE 89 EUROPE: EMPTY CAPSULES MARKET FOR ANTIBIOTICS & ANTIBACTERIAL DRUGS, BY COUNTRY, 2022-2029 (USD MILLION) 146
TABLE 90 ASIA PACIFIC: EMPTY CAPSULES MARKET FOR ANTIBIOTICS & ANTIBACTERIAL DRUGS, BY COUNTRY, 2022-2029 (USD MILLION) 146
TABLE 91 LATIN AMERICA: EMPTY CAPSULES MARKET FOR ANTIBIOTICS & ANTIBACTERIAL DRUGS, BY COUNTRY, 2022-2029 (USD MILLION) 147
8.3 DIETARY SUPPLEMENTS 147
8.3.1 HIGH UPTAKE OF MULTIVITAMINS TO BOOST DEMAND 147
TABLE 92 EMPTY CAPSULES MARKET FOR DIETARY SUPPLEMENTS, BY REGION, 2022-2029 (USD MILLION) 148
TABLE 93 NORTH AMERICA: EMPTY CAPSULES MARKET FOR DIETARY SUPPLEMENTS, BY COUNTRY, 2022-2029 (USD MILLION) 148
TABLE 94 EUROPE: EMPTY CAPSULES MARKET FOR DIETARY SUPPLEMENTS, BY COUNTRY, 2022-2029 (USD MILLION) 148
TABLE 95 ASIA PACIFIC: EMPTY CAPSULES MARKET FOR DIETARY SUPPLEMENTS, BY COUNTRY, 2022-2029 (USD MILLION) 149
TABLE 96 LATIN AMERICA: EMPTY CAPSULES MARKET FOR DIETARY SUPPLEMENTS, BY COUNTRY, 2022-2029 (USD MILLION) 149
8.4 ANTACID & ANTIFLATULENT PREPARATIONS 149
8.4.1 APPLICATIONS IN GASTROINTESTINAL FORMULATIONS TO DRIVE MARKET 149
TABLE 97 EMPTY CAPSULES MARKET FOR ANTACID & ANTIFLATULENT PREPARATIONS, BY REGION, 2022-2029 (USD MILLION) 150
TABLE 98 NORTH AMERICA: EMPTY CAPSULES MARKET FOR ANTACID & ANTIFLATULENT PREPARATIONS, BY COUNTRY, 2022-2029 (USD MILLION) 150
TABLE 99 EUROPE: EMPTY CAPSULES MARKET FOR ANTACID & ANTIFLATULENT PREPARATIONS, BY COUNTRY, 2022-2029 (USD MILLION) 151
TABLE 100 ASIA PACIFIC: EMPTY CAPSULES MARKET FOR ANTACID & ANTIFLATULENT PREPARATIONS, BY COUNTRY, 2022-2029 (USD MILLION) 151
TABLE 101 LATIN AMERICA: EMPTY CAPSULES MARKET FOR ANTACID AND ANTIFLATULENT PREPARATIONS, BY COUNTRY, 2022-2029 (USD MILLION) 152
8.5 ANTIANEMIC PREPARATIONS 152
8.5.1 RISING PREVALENCE OF ANEMIA TO SUPPORT MARKET GROWTH 152
TABLE 102 EMPTY CAPSULES MARKET FOR ANTIANEMIC PREPARATIONS, BY REGION, 2022-2029 (USD MILLION) 152
TABLE 103 NORTH AMERICA: EMPTY CAPSULES MARKET FOR ANTIANEMIC PREPARATIONS, BY COUNTRY, 2022-2029 (USD MILLION) 153
TABLE 104 EUROPE: EMPTY CAPSULES MARKET FOR ANTIANEMIC PREPARATIONS, BY COUNTRY, 2022-2029 (USD MILLION) 153
TABLE 105 ASIA PACIFIC: EMPTY CAPSULES MARKET FOR ANTIANEMIC PREPARATIONS, BY COUNTRY, 2022-2029 (USD MILLION) 153
TABLE 106 LATIN AMERICA: EMPTY CAPSULES MARKET FOR ANTIANEMIC PREPARATIONS, BY COUNTRY, 2022-2029 (USD MILLION) 154
8.6 ANTI-INFLAMMATORY DRUGS 154
8.6.1 GROWING PREFERENCE FOR NSAIDS AND DMARDS TO PROPEL MARKET 154
TABLE 107 EMPTY CAPSULES MARKET FOR ANTI-INFLAMMATORY DRUGS, BY REGION, 2022-2029 (USD MILLION) 155
TABLE 108 NORTH AMERICA: EMPTY CAPSULES MARKET FOR ANTI-INFLAMMATORY DRUGS, BY COUNTRY, 2022-2029 (USD MILLION) 155
TABLE 109 EUROPE: EMPTY CAPSULES MARKET FOR ANTI-INFLAMMATORY DRUGS, BY COUNTRY, 2022-2029 (USD MILLION) 155
TABLE 110 ASIA PACIFIC: EMPTY CAPSULES MARKET FOR ANTI-INFLAMMATORY DRUGS, BY COUNTRY, 2022-2029 (USD MILLION) 156
TABLE 111 LATIN AMERICA: EMPTY CAPSULES MARKET FOR ANTI-INFLAMMATORY DRUGS, BY COUNTRY, 2022-2029 (USD MILLION) 156
8.7 CARDIOVASCULAR THERAPY DRUGS 156
8.7.1 INCREASING PREVALENCE OF CVD TO SUPPORT MARKET GROWTH 156
TABLE 112 EMPTY CAPSULES MARKET FOR CARDIOVASCULAR THERAPY DRUGS, BY REGION, 2022-2029 (USD MILLION) 157
TABLE 113 NORTH AMERICA: EMPTY CAPSULES MARKET FOR CARDIOVASCULAR THERAPY DRUGS, BY COUNTRY, 2022-2029 (USD MILLION) 157
TABLE 114 EUROPE: EMPTY CAPSULES MARKET FOR CARDIOVASCULAR THERAPY DRUGS, BY COUNTRY, 2022-2029 (USD MILLION) 158
TABLE 115 ASIA PACIFIC: EMPTY CAPSULES MARKET FOR CARDIOVASCULAR THERAPY DRUGS, BY COUNTRY, 2022-2029 (USD MILLION) 158
TABLE 116 LATIN AMERICA: EMPTY CAPSULES MARKET FOR CARDIOVASCULAR THERAPY DRUGS, BY COUNTRY, 2022-2029 (USD MILLION) 159
8.8 COUGH & COLD DRUGS 159
8.8.1 GROWING PREFERENCE FOR OTC FORMULATIONS TO BOOST DEMAND 159
TABLE 117 EMPTY CAPSULES MARKET FOR COUGH & COLD DRUGS, BY REGION, 2022-2029 (USD MILLION) 160
TABLE 118 NORTH AMERICA: EMPTY CAPSULES MARKET FOR COUGH & COLD DRUGS, BY COUNTRY, 2022-2029 (USD MILLION) 160
TABLE 119 EUROPE: EMPTY CAPSULES MARKET FOR COUGH & COLD DRUGS, BY COUNTRY, 2022-2029 (USD MILLION) 160
TABLE 120 ASIA PACIFIC: EMPTY CAPSULES MARKET FOR COUGH & COLD DRUGS, BY COUNTRY, 2022-2029 (USD MILLION) 161
TABLE 121 LATIN AMERICA: EMPTY CAPSULES MARKET FOR COUGH & COLD DRUGS, BY COUNTRY, 2022-2029 (USD MILLION) 161
8.9 OTHER THERAPEUTIC APPLICATIONS 161
TABLE 122 EMPTY CAPSULES MARKET FOR OTHER THERAPEUTIC APPLICATIONS, BY REGION, 2022-2029 (USD MILLION) 162
TABLE 123 NORTH AMERICA: EMPTY CAPSULES MARKET FOR OTHER THERAPEUTIC APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION) 162
TABLE 124 EUROPE: EMPTY CAPSULES MARKET FOR OTHER THERAPEUTIC APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION) 162
TABLE 125 ASIA PACIFIC: EMPTY CAPSULES MARKET FOR OTHER THERAPEUTIC APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION) 163
TABLE 126 LATIN AMERICA: EMPTY CAPSULES MARKET FOR OTHER THERAPEUTIC APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION) 163
9 EMPTY CAPSULES MARKET, BY END USER 164
9.1 INTRODUCTION 165
TABLE 127 EMPTY CAPSULES MARKET, BY END USER, 2022-2029 (USD MILLION) 165
9.2 PHARMACEUTICAL INDUSTRY 165
9.2.1 INCREASING FOCUS ON DRUG DISCOVERY & DEVELOPMENT ACTIVITIES TO PROPEL MARKET 165
TABLE 128 EMPTY CAPSULES MARKET FOR PHARMACEUTICAL INDUSTRY, BY REGION, 2022-2029 (USD MILLION) 166
TABLE 129 NORTH AMERICA: EMPTY CAPSULES MARKET FOR PHARMACEUTICAL INDUSTRY, BY COUNTRY, 2022-2029 (USD MILLION) 166
TABLE 130 EUROPE: EMPTY CAPSULES MARKET FOR PHARMACEUTICAL INDUSTRY, BY COUNTRY, 2022-2029 (USD MILLION) 167
TABLE 131 ASIA PACIFIC: EMPTY CAPSULES MARKET FOR PHARMACEUTICAL INDUSTRY, BY COUNTRY, 2022-2029 (USD MILLION) 167
TABLE 132 LATIN AMERICA: EMPTY CAPSULES MARKET FOR PHARMACEUTICAL INDUSTRY, BY COUNTRY, 2022-2029 (USD MILLION) 168
9.3 NUTRACEUTICAL INDUSTRY 168
9.3.1 GROWING DEMAND FOR DIETARY SUPPLEMENTS TO BOOST DEMAND 168
TABLE 133 EMPTY CAPSULES MARKET FOR NUTRACEUTICAL INDUSTRY, BY REGION, 2022-2029 (USD MILLION) 169
TABLE 134 NORTH AMERICA: EMPTY CAPSULES MARKET FOR NUTRACEUTICAL INDUSTRY, BY COUNTRY, 2022-2029 (USD MILLION) 169
TABLE 135 EUROPE: EMPTY CAPSULES MARKET FOR NUTRACEUTICAL INDUSTRY, BY COUNTRY, 2022-2029 (USD MILLION) 169
TABLE 136 ASIA PACIFIC: EMPTY CAPSULES MARKET FOR NUTRACEUTICAL INDUSTRY, BY COUNTRY, 2022-2029 (USD MILLION) 170
TABLE 137 LATIN AMERICA: EMPTY CAPSULES MARKET FOR NUTRACEUTICAL INDUSTRY, BY COUNTRY, 2022-2029 (USD MILLION) 170
9.4 COSMETICS INDUSTRY 170
9.4.1 RISING FOCUS ON HOLISTIC WELLNESS TO SUPPORT MARKET GROWTH 170
TABLE 138 EMPTY CAPSULES MARKET FOR COSMETIC INDUSTRY, BY REGION, 2022-2029 (USD MILLION) 171
TABLE 139 NORTH AMERICA: EMPTY CAPSULES MARKET FOR COSMETIC INDUSTRY, BY COUNTRY, 2022-2029 (USD MILLION) 171
TABLE 140 EUROPE: EMPTY CAPSULES MARKET FOR COSMETIC INDUSTRY, BY COUNTRY, 2022-2029 (USD MILLION) 172
TABLE 141 ASIA PACIFIC: EMPTY CAPSULES MARKET FOR COSMETIC INDUSTRY, BY COUNTRY, 2022-2029 (USD MILLION) 172
TABLE 142 LATIN AMERICA: EMPTY CAPSULES MARKET FOR COSMETIC INDUSTRY, BY COUNTRY, 2022-2029 (USD MILLION) 173
9.5 RESEARCH LABORATORIES 173
9.5.1 INCREASING CLINICAL TRIALS TO SUPPORT MARKET GROWTH 173
TABLE 143 EMPTY CAPSULES MARKET FOR RESEARCH LABORATORIES, BY REGION, 2022-2029 (USD MILLION) 174
TABLE 144 NORTH AMERICA: EMPTY CAPSULES MARKET FOR RESEARCH LABORATORIES, BY COUNTRY, 2022-2029 (USD MILLION) 174
TABLE 145 EUROPE: EMPTY CAPSULES MARKET FOR RESEARCH LABORATORIES, BY COUNTRY, 2022-2029 (USD MILLION) 174
TABLE 146 ASIA PACIFIC: EMPTY CAPSULES MARKET FOR RESEARCH LABORATORIES, BY COUNTRY, 2022-2029 (USD MILLION) 175
TABLE 147 LATIN AMERICA: EMPTY CAPSULES MARKET FOR RESEARCH LABORATORIES, BY COUNTRY, 2022-2029 (USD MILLION) 175
10 EMPTY CAPSULES MARKET, BY REGION 176
10.1 INTRODUCTION 177
TABLE 148 EMPTY CAPSULES MARKET, BY REGION, 2022-2029 (USD MILLION) 177
TABLE 149 EMPTY CAPSULES MARKET, BY REGION, 2022-2029 (BILLION UNITS) 177
10.2 NORTH AMERICA 178
10.2.1 NORTH AMERICA: RECESSION IMPACT 178
FIGURE 31 NORTH AMERICA: EMPTY CAPSULES MARKET SNAPSHOT 179
TABLE 150 NORTH AMERICA: EMPTY CAPSULES MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 179
TABLE 151 NORTH AMERICA: EMPTY CAPSULES MARKET, BY TYPE, 2022-2029 (USD MILLION) 180
TABLE 152 NORTH AMERICA: GELATIN CAPSULES MARKET, BY TYPE, 2022-2029 (USD MILLION) 180
TABLE 153 NORTH AMERICA: NON-GELATIN CAPSULES MARKET, BY TYPE, 2022-2029 (USD MILLION) 180
TABLE 154 NORTH AMERICA: EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2022-2029 (USD MILLION) 181
TABLE 155 NORTH AMERICA: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2022-2029 (USD MILLION) 181
TABLE 156 NORTH AMERICA: EMPTY CAPSULES MARKET, BY END USER, 2022-2029 (USD MILLION) 182
10.2.2 US 182
10.2.2.1 Rising demand for generic drugs to fuel market 182
TABLE 157 US: EMPTY CAPSULES MARKET, BY TYPE, 2022-2029 (USD MILLION) 183
TABLE 158 US: GELATIN CAPSULES MARKET, BY TYPE, 2022-2029 (USD MILLION) 183
TABLE 159 US: NON-GELATIN CAPSULES MARKET, BY TYPE, 2022-2029 (USD MILLION) 183
TABLE 160 US: EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2022-2029 (USD MILLION) 184
TABLE 161 US: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2022-2029 (USD MILLION) 184
TABLE 162 US: EMPTY CAPSULES MARKET, BY END USER, 2022-2029 (USD MILLION) 185
10.2.3 CANADA 185
10.2.3.1 Growing focus on nutraceutical exports to propel market 185
TABLE 163 CANADA: EMPTY CAPSULES MARKET, BY TYPE, 2022-2029 (USD MILLION) 186
TABLE 164 CANADA: GELATIN CAPSULES MARKET, BY TYPE, 2022-2029 (USD MILLION) 186
TABLE 165 CANADA: NON-GELATIN CAPSULES MARKET, BY TYPE, 2022-2029 (USD MILLION) 186
TABLE 166 CANADA: EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2022-2029 (USD MILLION) 187
TABLE 167 CANADA: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2022-2029 (USD MILLION) 187
TABLE 168 CANADA: EMPTY CAPSULES MARKET, BY END USER, 2022-2029 (USD MILLION) 188
10.3 EUROPE 189
10.3.1 EUROPE: RECESSION IMPACT 189
TABLE 169 EUROPE: EMPTY CAPSULES MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 189
TABLE 170 EUROPE: EMPTY CAPSULES MARKET, BY TYPE, 2022-2029 (USD MILLION) 190
TABLE 171 EUROPE: GELATIN CAPSULES MARKET, BY TYPE, 2022-2029 (USD MILLION) 190
TABLE 172 EUROPE: NON-GELATIN CAPSULES MARKET, BY TYPE, 2022-2029 (USD MILLION) 190
TABLE 173 EUROPE: EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2022-2029 (USD MILLION) 191
TABLE 174 EUROPE: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2022-2029 (USD MILLION) 191
TABLE 175 EUROPE: EMPTY CAPSULES MARKET, BY END USER, 2022-2029 (USD MILLION) 192
10.3.2 GERMANY 192
10.3.2.1 High demand for capsule-based pharma & nutraceutical formulations to propel market 192
TABLE 176 GERMANY: EMPTY CAPSULES MARKET, BY TYPE, 2022-2029 (USD MILLION) 193
TABLE 177 GERMANY: GELATIN CAPSULES MARKET, BY TYPE, 2022-2029 (USD MILLION) 193
TABLE 178 GERMANY: NON-GELATIN CAPSULES MARKET, BY TYPE, 2022-2029 (USD MILLION) 193
TABLE 179 GERMANY: EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2022-2029 (USD MILLION) 194
TABLE 180 GERMANY: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2022-2029 (USD MILLION) 194
TABLE 181 GERMANY: EMPTY CAPSULES MARKET, BY END USER, 2022-2029 (USD MILLION) 195
10.3.3 UK 195
10.3.3.1 Low cost of generics to boost demand 195
TABLE 182 UK: EMPTY CAPSULES MARKET, BY TYPE, 2022-2029 (USD MILLION) 195
TABLE 183 UK: GELATIN CAPSULES MARKET, BY TYPE, 2022-2029 (USD MILLION) 196
TABLE 184 UK: NON-GELATIN CAPSULES MARKET, BY TYPE, 2022-2029 (USD MILLION) 196
TABLE 185 UK: EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2022-2029 (USD MILLION) 196
TABLE 186 UK: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2022-2029 (USD MILLION) 197
TABLE 187 UK: EMPTY CAPSULES MARKET, BY END USER, 2022-2029 (USD MILLION) 197
10.3.4 FRANCE 197
10.3.4.1 Ban on bovine-based food-grade gelatin to restrain market 197
TABLE 188 FRANCE: EMPTY CAPSULES MARKET, BY TYPE, 2022-2029 (USD MILLION) 198
TABLE 189 FRANCE: GELATIN CAPSULES MARKET, BY TYPE, 2022-2029 (USD MILLION) 198
TABLE 190 FRANCE: NON-GELATIN CAPSULES MARKET, BY TYPE, 2022-2029 (USD MILLION) 199
TABLE 191 FRANCE: EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2022-2029 (USD MILLION) 199
TABLE 192 FRANCE: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2022-2029 (USD MILLION) 200
TABLE 193 FRANCE: EMPTY CAPSULES MARKET, BY END USER, 2022-2029 (USD MILLION) 200
10.3.5 ITALY 200
10.3.5.1 High R&D spending to support market growth 200
TABLE 194 ITALY: EMPTY CAPSULES MARKET, BY TYPE, 2022-2029 (USD MILLION) 201
TABLE 195 ITALY: GELATIN CAPSULES MARKET, BY TYPE, 2022-2029 (USD MILLION) 201
TABLE 196 ITALY: NON-GELATIN CAPSULES MARKET, BY TYPE, 2022-2029 (USD MILLION) 202
TABLE 197 ITALY: EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2022-2029 (USD MILLION) 202
TABLE 198 ITALY: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2022-2029 (USD MILLION) 203
TABLE 199 ITALY: EMPTY CAPSULES MARKET, BY END USER, 2022-2029 (USD MILLION) 203
10.3.6 SPAIN 204
10.3.6.1 Low production costs to drive market 204
TABLE 200 SPAIN: EMPTY CAPSULES MARKET, BY TYPE, 2022-2029 (USD MILLION) 204
TABLE 201 SPAIN: GELATIN CAPSULES MARKET, BY TYPE, 2022-2029 (USD MILLION) 204
TABLE 202 SPAIN: NON-GELATIN CAPSULES MARKET, BY TYPE, 2022-2029 (USD MILLION) 205
TABLE 203 SPAIN: EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2022-2029 (USD MILLION) 205
TABLE 204 SPAIN: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2022-2029 (USD MILLION) 206
TABLE 205 SPAIN: EMPTY CAPSULES MARKET, BY END USER, 2022-2029 (USD MILLION) 206
10.3.7 REST OF EUROPE 207
TABLE 206 REST OF EUROPE: EMPTY CAPSULES MARKET, BY TYPE, 2022-2029 (USD MILLION) 207
TABLE 207 REST OF EUROPE: GELATIN CAPSULES MARKET, BY TYPE, 2022-2029 (USD MILLION) 207
TABLE 208 REST OF EUROPE: NON-GELATIN CAPSULES MARKET, BY TYPE, 2022-2029 (USD MILLION) 208
TABLE 209 REST OF EUROPE: EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2022-2029 (USD MILLION) 208
TABLE 210 REST OF EUROPE: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2022-2029 (USD MILLION) 209
TABLE 211 REST OF EUROPE: EMPTY CAPSULES MARKET, BY END USER, 2022-2029 (USD MILLION) 209
10.4 ASIA PACIFIC 210
10.4.1 ASIA PACIFIC: RECESSION IMPACT 210
FIGURE 32 ASIA PACIFIC: EMPTY CAPSULES MARKET SNAPSHOT 211
TABLE 212 ASIA PACIFIC: EMPTY CAPSULES MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 212
TABLE 213 ASIA PACIFIC: EMPTY CAPSULES MARKET, BY TYPE, 2022-2029 (USD MILLION) 212
TABLE 214 ASIA PACIFIC: GELATIN CAPSULES MARKET, BY TYPE, 2022-2029 (USD MILLION) 212
TABLE 215 ASIA PACIFIC: NON-GELATIN CAPSULES MARKET, BY TYPE, 2022-2029 (USD MILLION) 213
TABLE 216 ASIA PACIFIC: EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2022-2029 (USD MILLION) 213
TABLE 217 ASIA PACIFIC: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2022-2029 (USD MILLION) 214
TABLE 218 ASIA PACIFIC: EMPTY CAPSULES MARKET, BY END USER, 2022-2029 (USD MILLION) 214
10.4.2 CHINA 215
10.4.2.1 Rising incidence of infectious diseases and increasing market 215
TABLE 219 CHINA: EMPTY CAPSULES MARKET, BY TYPE, 2022-2029 (USD MILLION) 215
TABLE 220 CHINA: GELATIN CAPSULES MARKET, BY TYPE, 2022-2029 (USD MILLION) 216
TABLE 221 CHINA: NON-GELATIN CAPSULES MARKET, BY TYPE, 2022-2029 (USD MILLION) 216
TABLE 222 CHINA: EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2022-2029 (USD MILLION) 216
TABLE 223 CHINA: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2022-2029 (USD MILLION) 217
TABLE 224 CHINA: EMPTY CAPSULES MARKET, BY END USER, 2022-2029 (USD MILLION) 217
10.4.3 INDIA 218
10.4.3.1 Growth in pharmaceutical industry to boost demand 218
TABLE 225 INDIA: EMPTY CAPSULES MARKET, BY TYPE, 2022-2029 (USD MILLION) 218
TABLE 226 INDIA: GELATIN CAPSULES MARKET, BY TYPE, 2022-2029 (USD MILLION) 219
TABLE 227 INDIA: NON-GELATIN CAPSULES MARKET, BY TYPE, 2022-2029 (USD MILLION) 219
TABLE 228 INDIA: EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2022-2029 (USD MILLION) 219
TABLE 229 INDIA: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2022-2029 (USD MILLION) 220
TABLE 230 INDIA: EMPTY CAPSULES MARKET, BY END USER, 2022-2029 (USD MILLION) 220
10.4.4 JAPAN 221
10.4.4.1 Rising advancements in drug delivery technologies to boost demand 221
TABLE 231 JAPAN: EMPTY CAPSULES MARKET, BY TYPE, 2022-2029 (USD MILLION) 221
TABLE 232 JAPAN: GELATIN CAPSULES MARKET, BY TYPE, 2022-2029 (USD MILLION) 222
TABLE 233 JAPAN: NON-GELATIN CAPSULES MARKET, BY TYPE, 2022-2029 (USD MILLION) 222
TABLE 234 JAPAN: EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2022-2029 (USD MILLION) 222
TABLE 235 JAPAN: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2022-2029 (USD MILLION) 223
TABLE 236 JAPAN: EMPTY CAPSULES MARKET, BY END USER, 2022-2029 (USD MILLION) 223
10.4.5 SOUTH KOREA 224
10.4.5.1 Presence of several pharmaceutical manufacturers to fuel market 224
TABLE 237 SOUTH KOREA: EMPTY CAPSULES MARKET, BY TYPE, 2022-2029 (USD MILLION) 224
TABLE 238 SOUTH KOREA: GELATIN CAPSULES MARKET, BY TYPE, 2022-2029 (USD MILLION) 224
TABLE 239 SOUTH KOREA: NON-GELATIN CAPSULES MARKET, BY TYPE, 2022-2029 (USD MILLION) 225
TABLE 240 SOUTH KOREA: EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2022-2029 (USD MILLION) 225
TABLE 241 SOUTH KOREA: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2022-2029 (USD MILLION) 226
TABLE 242 SOUTH KOREA: EMPTY CAPSULES MARKET, BY END USER, 2022-2029 (USD MILLION) 226
10.4.6 REST OF ASIA PACIFIC 227
TABLE 243 REST OF ASIA PACIFIC: EMPTY CAPSULES MARKET, BY TYPE, 2022-2029 (USD MILLION) 227
TABLE 244 REST OF ASIA PACIFIC: GELATIN CAPSULES MARKET, BY TYPE, 2022-2029 (USD MILLION) 227
TABLE 245 REST OF ASIA PACIFIC: NON-GELATIN CAPSULES MARKET, BY TYPE, 2022-2029 (USD MILLION) 228
TABLE 246 REST OF ASIA PACIFIC: EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2022-2029 (USD MILLION) 228
TABLE 247 REST OF ASIA PACIFIC: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2022-2029 (USD MILLION) 229
TABLE 248 REST OF ASIA PACIFIC: EMPTY CAPSULES MARKET, BY END USER, 2022-2029 (USD MILLION) 229
10.5 LATIN AMERICA 230
10.5.1 LATIN AMERICA: RECESSION IMPACT 230
TABLE 249 LATIN AMERICA: EMPTY CAPSULES MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 230
TABLE 250 LATIN AMERICA: EMPTY CAPSULES MARKET, BY TYPE, 2022-2029 (USD MILLION) 231
TABLE 251 LATIN AMERICA: GELATIN CAPSULES MARKET, BY TYPE, 2022-2029 (USD MILLION) 231
TABLE 252 LATIN AMERICA: NON-GELATIN CAPSULES MARKET, BY TYPE, 2022-2029 (USD MILLION) 231
TABLE 253 LATIN AMERICA: EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2022-2029 (USD MILLION) 232
TABLE 254 LATIN AMERICA: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2022-2029 (USD MILLION) 232
TABLE 255 LATIN AMERICA: EMPTY CAPSULES MARKET, BY END USER, 2022-2029 (USD MILLION) 233
10.5.2 BRAZIL 233
10.5.2.1 High export of generics to support market growth 233
TABLE 256 BRAZIL: EMPTY CAPSULES MARKET, BY TYPE, 2022-2029 (USD MILLION) 233
TABLE 257 BRAZIL: GELATIN CAPSULES MARKET, BY TYPE, 2022-2029 (USD MILLION) 234
TABLE 258 BRAZIL: NON-GELATIN CAPSULES MARKET, BY TYPE, 2022-2029 (USD MILLION) 234
TABLE 259 BRAZIL: EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2022-2029 (USD MILLION) 234
TABLE 260 BRAZIL: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2022-2029 (USD MILLION) 235
TABLE 261 BRAZIL: EMPTY CAPSULES MARKET, BY END USER, 2022-2029 (USD MILLION) 235
10.5.3 MEXICO 236
10.5.3.1 Favorable healthcare regulations to fuel market 236
TABLE 262 MEXICO: EMPTY CAPSULES MARKET, BY TYPE, 2022-2029 (USD MILLION) 236
TABLE 263 MEXICO: GELATIN CAPSULES MARKET, BY TYPE, 2022-2029 (USD MILLION) 236
TABLE 264 MEXICO: NON-GELATIN CAPSULES MARKET, BY TYPE, 2022-2029 (USD MILLION) 237
TABLE 265 MEXICO: EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2022-2029 (USD MILLION) 237
TABLE 266 MEXICO: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2022-2029 (USD MILLION) 238
TABLE 267 MEXICO: EMPTY CAPSULES MARKET, BY END USER, 2022-2029 (USD MILLION) 238
10.5.4 REST OF LATIN AMERICA 239
TABLE 268 REST OF LATIN AMERICA: EMPTY CAPSULES MARKET, BY TYPE, 2022-2029 (USD MILLION) 239
TABLE 269 REST OF LATIN AMERICA: GELATIN CAPSULES MARKET, BY TYPE, 2022-2029 (USD MILLION) 240
TABLE 270 REST OF LATIN AMERICA: NON-GELATIN CAPSULES MARKET, BY TYPE, 2022-2029 (USD MILLION) 240
TABLE 271 REST OF LATIN AMERICA: EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2022-2029 (USD MILLION) 240
TABLE 272 REST OF LATIN AMERICA: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2022-2029 (USD MILLION) 241
TABLE 273 REST OF LATIN AMERICA: EMPTY CAPSULES MARKET, BY END USER, 2022-2029 (USD MILLION) 241
10.6 MIDDLE EAST 242
10.6.1 RISING DEMAND FOR HALAL-CERTIFIED PRODUCTS TO DRIVE MARKET 242
10.6.2 MIDDLE EAST: RECESSION IMPACT 242
TABLE 274 MIDDLE EAST: EMPTY CAPSULES MARKET, BY TYPE, 2022-2029 (USD MILLION) 242
TABLE 275 MIDDLE EAST: GELATIN CAPSULES MARKET, BY TYPE, 2022-2029 (USD MILLION) 243
TABLE 276 MIDDLE EAST: NON-GELATIN CAPSULES MARKET, BY TYPE, 2022-2029 (USD MILLION) 243
TABLE 277 MIDDLE EAST: EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2022-2029 (USD MILLION) 243
TABLE 278 MIDDLE EAST: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2022-2029 (USD MILLION) 244
TABLE 279 MIDDLE EAST: EMPTY CAPSULES MARKET, BY END USER, 2022-2029 (USD MILLION) 244
10.7 AFRICA 245
10.7.1 RISING FOCUS ON API DEVELOPMENT TO SUPPORT MARKET GROWTH 245
10.7.2 AFRICA: RECESSION IMPACT 245
TABLE 280 AFRICA: EMPTY CAPSULES MARKET, BY TYPE, 2022-2029 (USD MILLION) 245
TABLE 281 AFRICA: GELATIN CAPSULES MARKET, BY TYPE, 2022-2029 (USD MILLION) 246
TABLE 282 AFRICA: NON-GELATIN CAPSULES MARKET, BY TYPE, 2022-2029 (USD MILLION) 246
TABLE 283 AFRICA: EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2022-2029 (USD MILLION) 246
TABLE 284 AFRICA: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2022-2029 (USD MILLION) 247
TABLE 285 AFRICA: EMPTY CAPSULES MARKET, BY END USER, 2022-2029 (USD MILLION) 247
11 COMPETITIVE LANDSCAPE 248
11.1 OVERVIEW 248
11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 248
11.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN EMPTY CAPSULES MARKET 248
TABLE 286 OVERVIEW OF STRATEGIES DEPLOYED BY KEY MANUFACTURING COMPANIES 248
11.3 REVENUE ANALYSIS 251
FIGURE 33 REVENUE ANALYSIS OF KEY PLAYERS IN EMPTY CAPSULES MARKET, 2021-2023 (USD MILLION) 251
11.4 MARKET SHARE ANALYSIS 252
FIGURE 34 EMPTY CAPSULES MARKET SHARE ANALYSIS, BY KEY PLAYER (2023) 252
TABLE 287 EMPTY CAPSULES MARKET: DEGREE OF COMPETITION 253
11.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023 254
11.5.1 STARS 254
11.5.2 EMERGING LEADERS 254
11.5.3 PERVASIVE PLAYERS 254
11.5.4 PARTICIPANTS 254
FIGURE 35 EMPTY CAPSULES MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023 255
11.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023 256
11.5.5.1 Company footprint 256
FIGURE 36 EMPTY CAPSULES MARKET: COMPANY FOOTPRINT 256
11.5.5.2 Region footprint 257
TABLE 288 EMPTY CAPSULES MARKET: REGION FOOTPRINT 257
11.5.5.3 Type footprint 258
TABLE 289 EMPTY CAPSULES MARKET: TYPE FOOTPRINT 258
11.5.5.4 Functionality footprint 259
TABLE 290 EMPTY CAPSULES MARKET: FUNCTIONALITY FOOTPRINT 259
11.5.5.5 End-user footprint 260
TABLE 291 EMPTY CAPSULES MARKET: END-USER FOOTPRINT 260
11.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023 261
11.6.1 PROGRESSIVE COMPANIES 261
11.6.2 RESPONSIVE COMPANIES 261
11.6.3 DYNAMIC COMPANIES 261
11.6.4 STARTING BLOCKS 261
FIGURE 37 EMPTY CAPSULES MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023 262
11.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023 263
TABLE 292 EMPTY CAPSULES MARKET: DETAILED LIST OF KEY STARTUPS/SMES 263
TABLE 293 EMPTY CAPSULES MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES 264
11.7 COMPANY VALUATION & FINANCIAL METRICS 265
FIGURE 38 EV/EBITDA OF KEY VENDORS 265
FIGURE 39 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS 265
11.8 BRAND/PRODUCT COMPARISON 266
FIGURE 40 EMPTY CAPSULES MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS 266
11.9 COMPETITIVE SCENARIO 267
11.9.1 PRODUCT LAUNCHES & APPROVALS 267
TABLE 294 EMPTY CAPSULES MARKET: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021- MAY 2024 267
11.9.2 DEALS 268
TABLE 295 EMPTY CAPSULES MARKET: DEALS, JANUARY 2021-MAY 2024 268
11.9.3 EXPANSIONS 269
TABLE 296 EMPTY CAPSULES MARKET: EXPANSIONS, JANUARY 2021-MAY 2024 269
11.9.4 OTHER DEVELOPMENTS 269
TABLE 297 EMPTY CAPSULES MARKET: OTHER DEVELOPMENTS, JANUARY 2021-MAY 2024 269
?
12 COMPANY PROFILES 270
(Business Overview, Products Offered, Recent Developments, MnM View Right to win, Strategic choices made, Weaknesses and competitive threats) *
12.1 KEY PLAYERS 270
12.1.1 CAPSUGEL (LONZA) 270
TABLE 298 LONZA: COMPANY OVERVIEW 270
FIGURE 41 LONZA: COMPANY SNAPSHOT (2023) 271
TABLE 299 CAPSUGEL (LONZA): PRODUCTS OFFERED 271
TABLE 300 CAPSUGEL (LONZA): PRODUCT LAUNCHES & APPROVALS, JANUARY 2021-MAY 2024 273
TABLE 301 CAPSUGEL (LONZA): OTHER DEVELOPMENTS, JANUARY 2021-MAY 2024 274
12.1.2 ACG 275
TABLE 302 ACG: COMPANY OVERVIEW 275
TABLE 303 ACG: PRODUCTS OFFERED 276
TABLE 304 ACG: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021-MAY 2024 276
TABLE 305 ACG: DEALS, JANUARY 2021-MAY 2024 277
TABLE 306 ACG: OTHER DEVELOPMENTS, JANUARY 2021-MAY 2024 277
12.1.3 QUALICAPS (ROQUETTE FRERES) 279
TABLE 307 QUALICAPS (ROQUETTE FRERES): COMPANY OVERVIEW 279
TABLE 308 QUALICAPS (ROQUETTE FRERES): PRODUCTS OFFERED 279
TABLE 309 QUALICAPS (ROQUETTE FRERES): PRODUCT LAUNCHES & APPROVALS, JANUARY 2021-MAY 2024 280
TABLE 310 QUALICAPS (ROQUETTE FRERES): DEALS, JANUARY 2021-MAY 2024 281
TABLE 311 QUALICAPS (ROQUETTE FRERES): OTHER DEVELOPMENTS, JANUARY 2021-MAY 2024 281
12.1.4 SUHEUNG 283
TABLE 312 SUHEUNG: COMPANY OVERVIEW 283
FIGURE 42 SUHEUNG: COMPANY SNAPSHOT (2023) 283
TABLE 313 SUHEUNG: PRODUCTS OFFERED 284
TABLE 314 SUHEUNG: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021-MAY 2024 285
12.1.5 SHANXI GUANGSHENG CAPSULE LIMITED 286
TABLE 315 SHANXI GUANGSHENG CAPSULE LIMITED: COMPANY OVERVIEW 286
TABLE 316 SHANXI GUANGSHENG CAPSULE LIMITED: PRODUCTS OFFERED 286
TABLE 317 SHANXI GUANGSHENG CAPSULE LIMITED: OTHER DEVELOPMENTS, JANUARY 2021- MAY 2024 287
12.1.6 CAPSCANADA (LYFE GROUP) 288
TABLE 318 CAPSCANADA (LYFE GROUP): COMPANY OVERVIEW 288
TABLE 319 CAPSCANADA (LYFE GROUP): PRODUCTS OFFERED 288
12.1.7 HEALTHCAPS INDIA 290
TABLE 320 HEALTHCAPS INDIA: COMPANY OVERVIEW 290
FIGURE 43 HEALTHCAPS INDIA: COMPANY SNAPSHOT (2022) 290
TABLE 321 HEALTHCAPS INDIA: PRODUCTS OFFERED 291
12.1.8 NECTAR LIFESCIENCES LTD. 292
TABLE 322 NECTAR LIFESCIENCES LTD.: COMPANY OVERVIEW 292
FIGURE 44 NECTAR LIFESCIENCES LTD.: COMPANY SNAPSHOT (2022) 293
TABLE 323 NECTAR LIFESCIENCES LTD.: PRODUCTS OFFERED 293
12.1.9 SUNIL HEALTHCARE LIMITED 294
TABLE 324 SUNIL HEALTHCARE LIMITED: COMPANY OVERVIEW 294
FIGURE 45 SUNIL HEALTHCARE LIMITED COMPANY SNAPSHOT (2022) 295
TABLE 325 SUNIL HEALTHCARE LIMITED: PRODUCTS OFFERED 295
12.1.10 FARMACAPSULAS 297
TABLE 326 FARMACAPSULAS: COMPANY OVERVIEW 297
TABLE 327 FARMACAPSULAS: PRODUCTS OFFERED 297
12.1.11 NATURAL CAPSULES LIMITED 298
TABLE 328 NATURAL CAPSULES LIMITED: COMPANY OVERVIEW 298
FIGURE 46 NATURAL CAPSULES LIMITED: COMPANY SNAPSHOT (2023) 298
TABLE 329 NATURAL CAPSULES LIMITED: PRODUCTS OFFERED 299
TABLE 330 NATURAL CAPSULES LIMITED: OTHER DEVELOPMENTS, JANUARY 2021-MAY 2024 300
12.1.12 ERAWAT PHARMA LIMITED 301
TABLE 331 ERAWAT PHARMA LIMITED: COMPANY OVERVIEW 301
TABLE 332 ERAWAT PHARMA LIMITED: PRODUCTS OFFERED 301
12.1.13 QINGDAO YIQING BIOTECHNOLOGY CO., LTD. (BAOTOU DONGBAO BIO-TECH CO., LTD.) 303
TABLE 333 QINGDAO YIQING BIOTECHNOLOGY CO., LTD. (BAOTOU DONGBAO BIO-TECH CO., LTD.): COMPANY OVERVIEW 303
FIGURE 47 BAOTOU DONGBAO BIO-TECH CO., LTD.: COMPANY SNAPSHOT (2022) 303
TABLE 334 QINGDAO YIQING BIOTECHNOLOGY CO., LTD. (BAOTOU DONGBAO BIO-TECH CO., LTD.): PRODUCTS OFFERED 304
TABLE 335 QINGDAO YIQING BIOTECHNOLOGY CO., LTD. (BAOTOU DONGBAO BIO-TECH CO., LTD.): PRODUCT LAUNCHES & APPROVALS, JANUARY 2021-MAY 2024 304
12.1.14 FORTCAPS (KUMAR ORGANIC PRODUCTS LIMITED) 305
TABLE 336 FORTCAPS (KUMAR ORGANIC PRODUCTS LIMITED): COMPANY OVERVIEW 305
TABLE 337 FORTCAPS (KUMAR ORGANIC PRODUCTS LIMITED): PRODUCTS OFFERED 305
TABLE 338 FORTCAPS (KUMAR ORGANIC PRODUCTS LIMITED): DEALS, JANUARY 2021-MAY 2024 306
12.1.15 COMED CHEMICALS LIMITED 307
TABLE 339 COMED CHEMICALS LIMITED: COMPANY OVERVIEW 307
FIGURE 48 COMED CHEMICALS LIMITED: COMPANY SNAPSHOT (2022) 308
TABLE 340 COMED CHEMICALS LIMITED: PRODUCTS OFFERED 308
12.2 OTHER PLAYERS 309
12.2.1 SAVIOURCAPS 309
TABLE 341 SAVIOURCAPS: COMPANY OVERVIEW 309
12.2.2 SHANXI JC BIOLOGICAL TECHNOLOGY CO. 310
TABLE 342 SHANXI JC BIOLOGICAL TECHNOLOGY CO.: COMPANY OVERVIEW 310
12.2.3 ROXLOR 310
TABLE 343 ROXLOR: COMPANY OVERVIEW 310
12.2.4 MEDISCA INC. 311
TABLE 344 MEDISCA INC.: COMPANY OVERVIEW 311
12.2.5 ZHEJIANG YUEXI CAPSULE CO., LTD. 311
TABLE 345 ZHEJIANG YUEXI CAPSULE CO., LTD.: COMPANY OVERVIEW 311
12.2.6 SHAOXING KANGKE CAPSULE CO., LTD. 313
TABLE 346 SHAOXING KANGKE CAPSULE CO., LTD.: BUSINESS OVERVIEW 313
12.2.7 ZHEJIANG HUILI CAPSULES CO., LTD. 314
TABLE 347 ZHEJIANG HUILI CAPSULES CO., LTD.: COMPANY OVERVIEW 314
12.2.8 SHAOXING ZHONGYA CAPSULE CO., LTD. 315
TABLE 348 SHAOXING ZHONGYA CAPSULE CO., LTD.: COMPANY OVERVIEW 315
12.2.9 SHING LIH FANG ENTERPRISE CO., LTD. 316
TABLE 349 SHING LIH FANG ENTERPRISE CO., LTD.: COMPANY OVERVIEW 316
12.2.10 LEFANCAPS 317
TABLE 350 LEFANCAPS: COMPANY OVERVIEW 317
12.2.11 CHEMCAPS LIMITED 318
TABLE 351 CHEMCAPS LIMITED: COMPANY OVERVIEW 318
12.2.12 BIO-CAPS INDIA LTD. 319
TABLE 352 BIO-CAPS INDIA LTD.: COMPANY OVERVIEW 319
12.2.13 BIOCAPS ENTERPRISE 320
TABLE 353 BIOCAPS ENTERPRISE: COMPANY OVERVIEW 320
12.2.14 SNAIL PHARMA INDUSTRY 321
TABLE 354 SNAIL PHARMA INDUSTRY: COMPANY OVERVIEW 321
12.2.15 BRIGHT PHARMA CAPS 322
TABLE 355 BRIGHT PHARMA CAPS: COMPANY OVERVIEW 322
12.2.16 SHREE PHARMA CAPS 323
TABLE 356 SHREE PHARMA CAPS: COMPANY OVERVIEW 323
*Details on Business Overview, Products Offered, Recent Developments, MnM View, Right to win, Strategic choices made, Weaknesses and competitive threats might not be captured in case of unlisted companies.
13 APPENDIX 324
13.1 DISCUSSION GUIDE 324
13.2 KNOWLEDGESTORE: MARKETSANDMARKETS SUBSCRIPTION PORTAL 329
13.3 CUSTOMIZATION OPTIONS 331
13.4 RELATED REPORTS 332
13.5 AUTHOR DETAILS 333
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security